about
Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impaRecent Clinical Trials in Osteoporosis: A Firm Foundation or Falling Short?Impact of Sex and Contact-to-Device Time on Clinical Outcomes in Acute ST-Segment Elevation Myocardial Infarction-Findings From the National Cardiovascular Data Registry.Characteristics of pediatric cardiovascular clinical trials registered on ClinicalTrials.gov.Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons?The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialtyUsing ClinicalTrials.gov to understand the state of clinical research in pulmonary, critical care, and sleep medicine.Portfolio of clinical research in adult cardiovascular disease as reflected in ClinicalTrials.govThe state of infectious diseases clinical trials: a systematic review of ClinicalTrials.gov.Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database.Compliance with results reporting at ClinicalTrials.gov.Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention.Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute CoronarDietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease.Prognostic significance of bleeding location and severity among patients with acute coronary syndromes.The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.govPredictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients HospitalSelection of Stent Type in Patients With Atrial Fibrillation Presenting With Acute Myocardial Infarction: An Analysis From the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry-Get With the Guidelines.Utilization, Characteristics, and In-Hospital Outcomes of Coronary Artery Bypass Grafting in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention OComparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease).Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events.International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial.Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial).The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsation.Race and Sex Differences in QRS Interval and Associated Outcome Among Patients with Left Ventricular Systolic Dysfunction.Precatheterization Use of P2Y12 Inhibitors in Non-ST-Elevation Myocardial Infarction Patients Undergoing Early Cardiac Catheterization and In-Hospital Coronary Artery Bypass Grafting: Insights From the National Cardiovascular Data Registry®.Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov.Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial.The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction.Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).Improvement in Care and Outcomes for Emergency Medical Service-Transported Patients With ST-Elevation Myocardial Infarction (STEMI) With and Without Prehospital Cardiac Arrest: A Mission: Lifeline STEMI Accelerator Study.Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction.Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines).Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial.Comparison of Incidence of Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block Versus Those With Normal QRS Duration.Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial.Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.
P50
Q26795428-04768406-037C-480D-87A8-D32A7C2A6555Q28552191-EE15962B-6CCD-4476-84EE-B014C245D765Q31154265-0AD4B43C-E70C-4941-8096-44C63F02B87CQ33708509-69574CB9-DFB8-4CB7-9A7E-B86999F2DCA8Q34145163-8A554A4E-D659-45CD-AF21-2B126324D44AQ34206436-B84DF8C9-3DE7-48B9-9B0D-264098F5054AQ34976309-15900980-BF16-4A99-9F33-A5941D59B275Q35000520-73F36EFF-0E40-4343-85F1-7D5CC0391B42Q35023047-7DDDDFE1-C8D0-4A64-AD0A-7BA867B44215Q35184566-0B6B1973-ED4E-4F5F-B2CF-86384F3BFEAAQ35575094-105D6D2B-E119-44D2-9DC4-4E953E6DDA9BQ36168700-88E74504-D947-47EE-A887-702F65951B9BQ36356524-FE14EE61-0D7F-4F57-9D9E-6360D81C7AFEQ37057109-EE7E1DD8-6F38-4BAC-8AAC-92898B297288Q37448908-F7346D76-29B4-420B-8054-0ACFA84E58D4Q37705268-682270C1-A326-4DDD-ADAB-5EC90A7F055CQ38440582-A76A9B04-92C3-4287-B5BF-B585BA569523Q38597914-1F19F3E6-DDE1-4A3F-A293-80C9C30EA632Q38631705-AF881132-D575-4083-B229-6C8887A7822BQ38732317-C91171CD-688A-4A34-A012-81BFDF063884Q38960401-314C81BD-57C2-478F-89F6-0CCDDF38E02BQ39168089-2CE948FB-D9E4-4753-925C-DABC7418F5C3Q39202662-43D92E1A-12CD-40CA-AAB2-C1351E84AF6EQ39472543-2D6F8BD2-AA10-41FA-8F9A-7DBE64586351Q39732849-43962E3C-14E3-47BD-8BFA-719729B515ABQ41103812-EB2F5041-9D84-4949-95CE-E86B79DB0A76Q42373733-30DB7AAD-268C-4247-87AB-86083D18978BQ42373747-AFC87080-3639-4F70-B761-79AF088FC5F5Q42600467-FECC7C66-DC41-4B3F-BB05-73038D906093Q44129824-83903A08-C315-4576-BE89-70B5B3591E55Q44840001-7283D8D7-5442-4B5C-BE17-73F229E5B63CQ46853609-65B9F1B0-041B-4803-8714-CA685152D606Q47108813-1F8D7EBD-B4FC-4E65-9FCE-1D1FE95CB135Q47190217-FEB04850-CF2D-4D1F-843D-6EC620945F1CQ47222907-83E0FF7C-D974-49D1-9D57-70072FDF5148Q47300249-F0637392-3CA5-4609-83E7-439AA548B318Q47317089-5B426058-1D6D-45E8-96D2-B06617A3B456Q47621820-B5CE306A-3332-41BA-89C1-2ABF35D1A912Q47687580-2EE5234C-7600-414B-9074-A720916DECCCQ47717067-FB01BC77-D1F5-4DE8-9143-93A45085B7C6
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Karen Chiswell
@ast
Karen Chiswell
@de
Karen Chiswell
@en
Karen Chiswell
@es
Karen Chiswell
@fr
Karen Chiswell
@it
Karen Chiswell
@nl
type
label
Karen Chiswell
@ast
Karen Chiswell
@de
Karen Chiswell
@en
Karen Chiswell
@es
Karen Chiswell
@fr
Karen Chiswell
@it
Karen Chiswell
@nl
prefLabel
Karen Chiswell
@ast
Karen Chiswell
@de
Karen Chiswell
@en
Karen Chiswell
@es
Karen Chiswell
@fr
Karen Chiswell
@it
Karen Chiswell
@nl
P106
P21
P31
P496
0000-0002-0279-9093